⚖UPC-Intel
🏛️ EPO Munich

EPO T 0420/25

Court
EPO Board of Appeal 3.3.07 (Munich)
Type of action
opposition appeal
Patent
EP3403646
LIQUID PHARMACEUTICAL COMPOSITION
Language
en
Claimant / applicant
  • Fresenius Kabi Deutschland GmbH
Defendant / respondent
  • Samsung Bioepis NL B.V.
  • Biogen Inc.

Track this case

Get an email when a new order or decision is published in EPO T 0420/25.

Decisions and documents (1)

Weekly digest

A weekly email summarising new published decisions across European patent courts.